References
- Corey E. J., Russey W. E., Ortiz De Montellano P. R. 2,3-Oxidosqualene, an intermediate in the biological synthesis of sterols from squalene. Journal of the American Chemical Society 1966; 88: 4750–4751
- Fischer F. G., Bielig H. J. Über die Hydrierung ungesättigter Stoffe im Tierkörper (Biochemische Hydrierungen VII). Hoppe-Seyler's Zeitschrift fur Physiologische Chemie 1940; 266: 73–98
- Fujimoto M., Yamanaka T., Bessho M., Igarashi T. Effects of geranylgeranylacetone on gastrointestinal secretion in rats. European Journal of Pharmacology 1982; 77: 113–118
- Goto Y., Debas H. T. Geranylgeranylacetone, a new acyclic polyisoprenoid antiulcer agent: mechanisms of action. Gastroenterology 1984; 86: 1094, Abstract
- Herdon J., Steinberg D., Uhlendorf B., Fales H. Refsum's disease: characterization of the enzyme defect in cell culture. Journal of Clinical Investigation 1969; 48: 1017–1032
- Hildebrandt H. Über das biologische Verhalten von Nerol, Geraniol, Cyclogeraniol. Beitrage zur Chemischen Physiologie und Pathologie 1904; 4: 251–253
- Imada I., Watanabe M., Matsumoto N., Morimoto H. Metabolism of ubiquinone-7. Biochemistry 1970; 9: 2870–2878
- Lazarow B. L. Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat. Science 1977; 197: 580–581
- Mayer H., Isler O. Synthesis of vitamins K. Methods in Enzymology, D. B. McCormick, L. D. Wright. Academic Press, New York 1971; Vol. 18: 492–547
- Murakami M., Oketani K., Fujisaki H., Wakabayashi T., Ohgo T. Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats. Arzneimittel Forschung (Drug Research) 1981a; 31: 799–804
- Murakami M., Muto M., Moriwaki H., Ohgo T. Effect of acyclic polyisoprenoids on the biosynthesis of mannose-labeled glycolipids in rat liver microsomes. Biochemical and Biophysical Research Communications 1981b; 103: 706–712
- Nishizawa Y., Yamada K., Yamato C., Fujita T. Metabolic fate of geranylgeranylacetone. Yakubutsudoutai 1986; 1: 171–177, in Japanese
- Oketani K., Murakami M., Fujisaki H., Wakabayashi T. Effect of geranylgeranylacetone on aspirin-induced changes in gastric glycoproteins. Japanese Journal of Pharmacology 1983; 33: 593–601
- Passi S., Nazzaro-Porro M., Picardo M., Mingrone G., Fasella P. Metabolism of straight saturated medium chain length (C9 to C12) dicarboxylic acids. Journal of Lipid Research 1983; 24: 1140–1147
- Shearer M. J., Barkhan P. Studies on the metabolites of phylloquinone (vitamin K1) in the urine of man. Biochimica et Biophysica Acta 1973; 297: 300–312
- Sporstøl S., Scheline R. R. The metabolism of 4-(4-hydroxyphenyl)butan-2-one (raspberry ketone) in rats, guinea-pigs and rabbits. Xenobiotica 1982; 12: 249–257
- Stoffel W., Ditzer R., Caesar Z. Der Stoffwechsel der ungesättigten Fettsäuren III. Zur β-Oxydation der Mono-und Polyenfettsäuren der Mechanismus der enzymatischen Reaktionen an Δ3cis-Enoyl-CoA-Verbindungen. Hoppe-Seyler's Zeitschrift fur Physiologische Chemie 1964; 339: 167–181
- Terano A., Matsumoto K., Motoki T., Murano S., Kamii K. Effect of prostaglandin E2, cimetidine and geranylgeranylacetone on rat gastric mucosal damage. Japanese Journal of Gastroenterology 1981; 78: 1577–1584
- Van Tamelen E. E., Willett J. D., Clayton R. B., Lord K. E. Enzymic conversion of squalene 2,3-oxide to lanosterol and cholesterol. Journal of the American Chemical Society 1966; 88: 4752–4754
- Yamada J., Horie S., Watanabe T., Suga T. Participation of peroxisomal system in the chain-shortening of a xenobiotic acyl compound. Biochemical and Biophysical Research Communications 1984; 30: 123–128